Tagged with " Platinol"
BMY “Consents” to Improper Orange Book Listings
March 7, 2003 The Federal Trade Commission today announced that Bristol-Myers Squibb Company (Bristol) – one of the world’s largest [...]
Site Directory
Areas of Expertise
Topics Investigated
Adderal XR
airlines
antitrust
asbestos
Augmentin
bankruptcy
Banks
Baycol
Benlate
Buspar
Claritin
class actions
correct prediction
diet drugs: fen phen
Epogen
FDA
Federal Trade Commission
Fosamax
fraud
generic drug suits
Hatch Waxman Act
insurance
International Trade Commission
Justice Department
Levaquin
Lipitor
mass torts
mergers
Neurontin
patent infringement suits
patents
Paxil
Platinol
Prilosec
product recalls
Prozac
rating agencies
securities
software
tax
Taxol
telephone
tobacco
trial coverage
Wellbrutrin
Companies Researched
Abbot Labs
ABI (American Bioscience)
ADM (Archer Daniel Midland)
Alpharpharma
American Home Products/Wyeth (AHP)
Amgen
AMR (American Airlines)
Andrx
Apotex
Archer Daniels Midland (ADM)
Astra- Zeneca (AZ)
Barr Labs
BMY (Bristol Myers)
Boeing
Cheminor
Columbia/HCA
Daiichi
Delta
Dupont
Geneva
Genpharm
Glaxo
Intel
IVAX
J&J
Kudco
Lilly
McDonald Douglas
Merck
Microsoft
Murdock (News America)
Mylan
Napro
Ortho MacNeil
Pfizer
Rambus
Ranbaxy
Sanofi-Aventis
Synthon
Teva
TKT
TorPharm
United
Valassis
Zenith
All original content copyright © 2011 Verdict for Investors, Inc. All rights reserved. All other products, services, and company names are trademarks, registered trademarks or service marks of their respective owners.